2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Pocket Pal
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee
Industry Education Workshop

Unmet needs in aSAH: Limitations of Current Nimodipine Therapy and Emerging Evidence

Tuesday, March 24, 2026
12:15 PM - 1:15 PM Central Time
Location: Connections Central Theater 2

Organized by Grace Therapeutics, Inc
Presenter: H. Alex Choi, MD
Orally administered nimodipine is standard of care for patients with aneurysmal subarachnoid hemorrhage, and giving the full‑dose regimen has been associated with better outcomes in these patients. However, many factors conspire to hinder full dosing, such as hypotension and gastrointestinal side effects. This workshop reviews the recommended prescribing of oral nimodipine and introduces data from a randomized clinical trial of a new intravenous nimodipine formulation (GTX‑104) that avoids the shortcomings of oral nimodipine.